The role of brachytherapy for margin control in oral tongue squamous cell carcinoma.

BACKGROUND: The aim of this study is to assess the feasibility and effectiveness of using peri-operative brachytherapy (BRTx) for positive/narrow margins present post primary surgical resection of oral tongue squamous cell carcinoma (OTSCC). METHODS: Prospective single-centre study of patients with OTSCC (T1-3, N0-3, M0) treated with resection of primary tumour ± regional nodal resection and intra-operative insertion of BRTx catheters. BRTx was administered twice daily at 40.8Gy/12Fr for 'Positive' (≤2 mm) margins, at 34Gy/10Fr for 'Narrow' (2.1-5 mm) margins, and not given for 'Clear' (> 5 mm) margins over the course of 5-6 days, 3-5 days post operatively. RESULTS: Out of 55 patients recruited 41 patients (74.6%) were treated with BRTx, as 12 patients had clear margins and 2 patients had unfavourable tumour anatomy for catheter insertion. EBRTx was avoided in 64.3% of patients. Overall Survival (OS) at 3 and 5 years was 75.6 and 59.1% respectively, while Disease Specific Survival (DSS) was 82.3 and 68.6% at 3 and 5 years respectively. Recurrence and survival outcomes were not associated with margin status or the use of or specific dose of BRTx on Cox regression analysis. Acute and late toxicity secondary to BRTx was minimal. CONCLUSIONS: The use of BRTx after primary OTSCC resection with positive/narrow margins ± EBRTx to the neck ± CTx achieves outcomes comparable to traditional treatment of surgery followed by re-resection or EBRTx ± CTx. Morbidity associated with oral cavity EBRTx or secondary resection and reconstruction is thus avoided. Both acute and late toxicity rates are low and compare favourably with other BRTx OTSCC studies. TRIAL REGISTRATION: Retrospectively registered. https://www.mcgill.ca/rcr-rcn/files/rcr-rcn/2017.06.05_rcn_hn.pdf . LEVEL OF EVIDENCE: 4.

Patient-perceived outcome after sialendoscopy using the glasgow benefit inventory.

OBJECTIVES/HYPOTHESIS: Sialendoscopy is a technique for investigating and managing obstructive salivary disease that avoids risks associated with the more invasive sialoadenectomy and other open surgery techniques. To date, surgeon-based outcomes have been reported, but only one report of patient-oriented outcomes has appeared in the literature. The objective of this study was to review our experience after introducing sialendoscopy to New Zealand and report the patient-perceived benefit. STUDY DESIGN: A prospective observational study of all sialendoscopic procedures performed in the only sialendoscopy-practicing center in New Zealand between June 2010 and June 2012. METHODS: Clinical and epidemiological data of all patients were recorded. Sialendoscopic findings, complications, and outcomes were noted. The Glasgow Benefit Inventory questionnaire was administered to the patients at their follow-up. RESULTS: Fifty-four patients underwent a total of 66 sialendoscopic procedures, involving 44 parotid and 22 submandibular glands. There was a complete symptom resolution in 54 procedures (82%). Sialolith removal was successful in 67% of cases, with postsialendoscopy symptom resolution in 86% of sialolithiasis cases. Symptoms resolved in 81% of cases with ductal stenosis. The overall mean Glasgow Benefit Inventory score was +31, which compares very favorably with other otolaryngology procedures. CONCLUSIONS: This study shows a substantial positive patient-perceived benefit of sialendoscopy for both sialolith- and stenosis-based pathology. The overall rate of symptom resolution is comparable to international literature. LEVEL OF EVIDENCE: 4.

Nasopharyngeal carcinoma: differences in presentation between different ethnicities in the New Zealand setting.

INTRODUCTION: There is an elevated incidence of nasopharyngeal carcinoma (NPC) in the Maori and Pacific Island (MPI) population as well as the Asian population in New Zealand; however, no studies have been conducted to evaluate how the two populations differ in their clinical presentation according to the TNM stage. METHODS: A retrospective review was conducted of all patients presenting to the Auckland City Hospital ENT department with a newly diagnosed NPC between the years 1995 and 2007 inclusive. The patient's radiological and biopsy results were reviewed, and each patient was staged according to the TNM stage at presentation as per the revised 2002 American Joint Committee on Cancer staging criteria. The Fisher's exact test was used to compare the differences between ethnicities in the T and N stages of the disease at presentation; the Cochran-Armitage Trend test was used to look for statistically significant trends. RESULTS: There was a statistically significant difference in T stage at presentation between MPIs and Asians (P < 0.0001), with a positive, statistically significant (P < 0.0001) trend indicating that MPIs present with greater T stage. A statistically significant difference in the N stage at diagnosis between MPIs and Asians, independent of the T stage, was found at stages T2 (P = 0.046) and T4 (P = 0.0083), with a statistically significant trend (T2 -P = 0.009; T4 -P = 0.026). CONCLUSIONS: These results show that MPIs have a more advanced local NPC disease than Asians at presentation, and that for specific T stages, the nodal disease is also more advanced than that found in Asians.

Neurological deficit as a presentation of occult metastatic thyroid carcinoma.

Three cases of occult metastatic thyroid carcinoma presenting with neurological deficits are reviewed. In each case the patient's initial presentation was with symptoms of neurological deficiency secondary to a spinal cord compression. All patients received a combination of surgery, external beam radiotherapy and postoperative thyroxine treatment. Two of the three patients are alive and well, able to mobilize with minor neurological dysfunction. The diagnosis and management of the patients, as well as their outcomes are reviewed, with a discussion on further management issues alongside a review of the current published work.